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Mesua ferrea L. (Calophyllaceae) exerts therapeutic effects in allergic asthma by
modulating cytokines production in asthmatic rats
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Abstract: In the present study, ethanolic extract of Mesua ferrea L. stamens was investigated for its potential to reverse some features of
bronchial asthma in ovalbumin-induced murine model of asthma. Mesua ferrea commonly called nagakeshar (Family, Calophyllaceae)
is a well-known antiallergic drug in the Asian folk system of medicines. In the present work, pharmacological studies are done to
provide scientific evidence for therapeutic potential of plants in allergic asthma. Asthma was induced in experimental rats with allergen
suspension of ovalbumin and aluminium hydroxide followed by treatment with dexamethasone (2.5 mg/kg, p.o) or M. ferrea stamen
extract (3.75 and 15 mg/kg, b.w., p.o). Biomarkers of inflammatory response including cell counts, Immunoglobulin E, cytokines
such as interleukin (IL)-4, -5, -1β, tumor necrosis factor (TNF)-α, leukotriene (LT)-D-4, and nitrite concentration in blood as well as
bronchial (BAL) fluid were tested. Lung functions in asthmatic and treated animals were evaluated as breathing rate and tidal volume.
Treatment with M. ferrea stamen extract (MFE) markedly (p < 0.001, p < 0.01 and p < 0.05) diminished infiltration of inflammatory
cells, IgE, cytokines, and nitrites in blood/serum and bronchial fluid. Improvement in lung functions (p < 0.05) of asthmatic animals
after MFE treatment also supports our findings. Results of the study suggest a therapeutic potential of M. ferrea in allergic asthma that
can be related to the ability of plants to attenuate the response of inflammatory cells and thereby, the production of inflammatory and
proinflammatory cytokines in airways.
Key words: Mesua ferrea extract, antiallergic, inflammatory cells, lung functions, airway remodeling

1. Introduction
Bronchial asthma is noncommunicable lung disorder
affecting 5%-10% of the world population or an estimated
23.4 million people, including 7 million children and
250,000 deaths.The annuall increase in asthma prevalence
by approximately, 3.6% makes disease a global issue
of public health (Asher et al., 2020). Bronchial asthma
is characterized by chronic inflammation, excessive
mucus formation, reversible constriction, and hyperresponsiveness of airways usually triggered by allergens
(WHO, 2020). Another pathological feature of asthma is
airway remodeling, described as structural and functional
changes in lungs attributed to persistent inflammatory
response in airways (Roh et al., 2008; Zeiger et al., 2014;
Fehrenbach, et al., 2017; Arora and Ansari, 2019). The
classical dogma of asthma is central to allergen induced
imbalance between TH1 and TH2 cytokines leading to
excessive production of TH2 cytokines, mainly, IL-4, IL-

5, and IL-ß, TNF-œ. IL-4 activates B cells to produce
IgE, in contrast, IL-5 has ability to activate migration and
infiltration of eosinophils, inducing eosinophilic airway
inflammation (Kuruvilla et al., 2019). Together with TH2
cells, innate lymphoid group 2 cells (ILC2) also play a key
role in augmenting TH2 response and production of IL-5
in the airways (Hirose et al., 2017). All these cardinal
features of bronchial asthma are observed in ovalbumin
(OVA) exposed lung tissues of Wistar rats also.
Glucocorticoids, widely accepted as mainstay
therapy in chronic asthma. These corticosteroids act by
modulating TH2 and nonspecific innate immune responses
in individuals. Other therapies, available in the form of
short-term and long-term relievers, have failed to control
symptoms of asthma completely and even intensive
treatment is found to be ineffective. Consequently, effort
should be made to identify new remedies for mitigating
this disorder. For decades, herbal drugs have been utilized
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as a source of new therapeutically active molecules,
scaffolds, pharmacophores, and chemotypes.
Mesua ferrea Linn. also known as Ceylon iron wood
or Nagakesara, is an evergreen medium to large size tree
belonging to the family, Calophyllaceae. It is indigenous
to Asia. Its flowers are highly attractive and beautiful
and hence, generally cultivated for ornamental purposes.
M. ferrea is ethnomedicinally used as an antipyretic,
antiasthmatic, cardiotonic, carminative, expectorant,
antiseptic, purgative, and blood purifier in many countries
of the Asian continent (Burkill, 1966, Parukutty and
Chandra, 1984; Rai et al., 2000; Anonymous, 2005). The
plant is also used in the treatment of chronic diseases like
gastritis, bronchitis, rheumatism, skin infections, piles and
is used as an antidote against snake and scorpion string.
Various parts of M. ferrea tree like, flowers, leaves
and seed kernels are attributed with medicinal properties.
High medicinal importance of M ferrea is due to the
presence of various bioactive phytocomponents including
glycosides, flavonoids, triglycerides, resins, sesquiterpenes,
fatty acids, steroids, tannins, and saponins (Figure 1)
(Chahar et al., 2013; Keawsa-Ard et al., 2015, Asif et al.,
2017; Sharma et al., 2017).
In several in vitro and in vivo studies, these
phytocompounds
have
exhibited
considerable
pharmacological activities including antimicrobial,
anticancer, antiinflammatory, antiulcer, antihistaminic,
central nervous system (CNS) depressant, antiarthritic,
anticonvulsant, immunomodulatory activity, antioxidant
and hepatoprotective activity, analgesic activity,
antispasmodic activity, antivenom activity, wound healing
and spermicidal in preclinical studies (Chahar et al., 2013;
Keawsa-Ard et al., 2015; Sharma et al., 2017; Asif et al.,
2017).
The plant has been indexed as an important constituent
of various traditional antiasthmatic herbal medicines
(Arora and Ansari, 2015) (Table 1). However, the role of
the plant in context to modulation of airway inflammation
and airway remodeling in allergic asthma has never been
reconnoitered. In our study, we have investigated the
potential of M. ferrea standardized stamens extract (MFE)
in ovalbumin-induced airway inflammation in asthmatic
animals.
2. Materials and methods
2.1. Chemicals
All the reagents of analytical grade were purchased from
commercial Sigma Aldrich suppliers and were used in
the research work. Standard ELISA kits of interleukins,
IL-4, IL-5, IL-1β, leukotriene, LTD4, immunoglobulin E
(IgE), tumor necrosis factor TNF-α, and calorimetric kit
of nitric oxide (NO) were used to estimate levels of these
biomarkers in treated and control rat groups.

2.2. Preparation and standardisation of M. ferrea flower
stamens extract
M. ferrea stamens were harvested from the University
botanical and medicinal garden of Dibrugarh University,
Dibrugarh, Assam, India. The harvested fresh flowers
were collected, and stamens were handpicked by foreships
and dried under shade. The plant sample was validated
by Dr. Singh, NISCAIR, India, with voucher number
NISCAIR/RHMD/consult/-2011-12/1752/52. The dried
stamens (250 g) were coarsely grounded and thoroughly
extracted with a mixture of ethanol and water (7:3) for 24
h at room temperature (32 ± 2°C) with periodic stirring.
The extracted content was filtered under a vacuum. The
filtrate was concentrated under reduced pressure to obtain
semisolid crude extract. The crude extract was placed in
lyophilizer to remove any residual solvent and dried at
-40 °C to obtain yellow-brown colored dried powder. The
lyophilized powdered extract was stored in a desiccator
until further use.
The percentage yield (%w/w) obtained of the dried
extract was 12.9 ± 1.64. All the quality control parameters
were performed for standardization of extract as per
the guidelines of Ayurvedic Pharmacopoeia of India
(Anonymous, 2008). The standardized extract was stored
at 2-8 °C till further use in experiments. For conducting
pharmacological studies with MFE, 15 g of lyophilized
dried powder was suspended in 100 mL of 0.1%
carboxymethyl cellulose to make a stable suspension for
oral administration in animals.
2.3. Study design for investigation of M. ferrea
standardized extract (MFE) treatment in ovalbumin
sensitized and challenged asthmatic rats
Thirty healthy male Wistar rats were weighed and divided
randomly into five groups (6 rats per group). All the
animals were shifted and allowed to acclimatize for 15
days under standard housing conditions (25 ± 2 ºC/50 ±
5% with a 12 h light/dark cycle) before commencement of
the experiment. The animals for the study were issued and
approved by the Institutional Animal Ethics Committee
(approval no. JHAEC/173/CPCSEA dt. 28.1.2000), Jamia
Hamdard, New Delhi, India.
Group 1 (N) rats served as normal control and received
vehicle (0.1% CMC w/v in purified water). Group 2 (S)
rats served as asthma control; Group 3 (S+D), received
standard drug, dexamethasone 2.5 mg/kg (D); Group
4 (S+M1) and Group 5 (S+M2) rats received MFE, 3.75
mg/kg (M1) and 15 mg/kg, b.w., (M2), respectively.
Treatments were given daily through oral route from day
1 to 28 between 10.00 to 11.00 a.m. Administered dose
of the M. ferrea stamens extract in rats was derived from
the daily recommended dose of the drug recommended
in Ayurvedic Pharmacopoeia of India (Anonymous,
2008). The standard reference drug used in the study was
corticosteroid dexamethasone.
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Figure 1. Major active phytoconstituents present in M. ferrea.

Asthma was induced in rats (group 2 to 5) by
administering suspension of ovalbumin (40 mg/animal)
and Al(OH)3 (2 mg/rat) (Arora et al., 2017). The suspension
of ovalbumin and aluminum hydroxide acts as an allergen
that activates the allergic response in the rats; and makes
them sensitized and susceptible to asthma.
After 15 days of i.p. administration of allergen
suspension, sensitized rats were exposed to mist of 1%
chick egg albumin (ovalbumin) suspension (1 mg/100 mL
normal saline) for 20 min in a closed chamber regularly
(once a day) for the next 8 consecutive days (day 15 to day
22) and thereafter, with a gap of 3 days i.e. on day 25 and
day 28. In control group animals (Group I) animals that
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were not sensitized by allergen (ovalbumin and aluminum
hydroxide), animals were exposed to a mist of normal
saline solution for the above specified time period.
2.4. Lung function test
Lung function was gaged using two parameters (i) breathing
rate and (ii) tidal volume. Rats were anaesthetized with
sodium pentobarbitone (i.p.,105 mg/kg) on the 28th day,
five min after challenging the OVA-sensitized rats. To
record airflow signals of the rat’s lung, the rat’s trachea
was connected with a spirometer (pneumotachograph)
and differential pressure transducer device (Parasuraman
and Raveendran, 2012). The transducer integrates the
electronic airflow signals into lungs tidal volume (VT,
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Table 1. List of some marketed formulation containing Mesua ferrea as an ingredient.
Marketed product

System of
medicine

Marketing company

Uses/indications

Maharisi amrit kalash-4

Ayurveda

Maharishi Ayurveda

Immunomodulator

Dasamoolarishta

Ayurveda

Baidyanath, Zandu

Appetizer, indigestion, liver diseases, piles, jaundice,
respiratory diseases

Shri gopal tail

Ayurveda

Baidyanath, Dabar

Erectile dysfunction, memory enhancer,
neuromuscular dysfunction

Sarivadi vati

Ayurveda

Baidyanath, Divya Pharmacy
(Patanjali)

Hearing problem, tinnitus and ear infections, epilepsy,
bleeding disorder

Jatiphaladi churna

Ayurveda

Baidyanath

Digestive and respiratory conditions

Drakshadi churnam

Ayurveda

Zandu

Digestive and respiratory conditions

Vyaghrihareetaki avaleha

Ayurveda

Zandu, Baidyanath, Patanjali

Cough, cold, asthma, bronchitis

Brahma Rasayana

Ayurveda

Dabar, Shri Shri Ayurveda,

Immunity booster, memory enhancer

Eladi churna/ vati

Siddha

Baidyanath

Carminative, vomiting, indigestion, anorexia

Lavangadi churna/ vati/tablet Siddha

Baidyanath, Dabar

Cough, diarrhea, dysentery, mouth diseases, dental
caries, anemia, and fever

Jawarish Shehryaran

Unani

Hamdard

Stomach and liver tonic

Halwa-i-supari pack

Unani

Hamdard

General digestive tonic

Kapooradi churnam

Siddha

SKM

Anorexia, indigestion, vomiting

mL/s) and breathing rate (f, breaths/min). Physiological
respiratory data were collected, analyzed with the help
of Power Lab System and LabChart Programme software
(spirometer Model no: FE141, ADInstruments, Pty,
Australia). Before recording data in L/s, the spirometer
was calibrated, and any drift in signals attributable to the
instrument transducer was neutralized for high precision.
Changes in f and VT were measured after intravenous (i.v.)
administration of vehicle (in normal control group) and
methacholine (1.5 mg/kg) in rats through femoral vein.
Heparin (0.5%) was administered to prevent any chances
of blood coagulation during study. One data point was
generated by recording and averaging 10-12 respiratory
cycles. To avoid disturbances arising due to spontaneous
respiration, an i.v. injection of vecuronium bromide at
the dose of 0.2 mg/kg was given to the anesthetized rats.
The excessive bronchial secretion produced during the
procedure was discharged by means of a small polyethylene
tube so that the trachea was not disturbed throughout the
procedure (Arora et al., 2017).
2.5. Collection of bronchial fluid (BAL) fluid
Bronchial fluid or bronchoalveolar fluid (BAL) fluid
was collected as per the procedure described by earlier
(Arora et al., 2017). Briefly, lungs were lavaged with 0.9%
physiological normal saline solution. The whole procedure
was repeated thrice with fresh 5 mL of physiological
solution. All the collected BAL fluids were mixed together

and centrifuged at 4500 rpm/4 ºC. The supernatant was
collected to analyse inflammatory biomarkers. The cell
pellet obtained after centrifugation was suspended in
normal saline (1 mL) and used for quantitative analyses
of total and differential leukocyte count in BAL fluid as
described earlier (Canning and Chou, 2008).
2.6. Estimation of cell count in blood and BAL fluid
The blood was collected via cardiac puncture using a
19-gauge sterile syringe. Two separate vials were used for
blood collection. In one vial, an anticoagulant (heparin)
was added and stored at 4 ºC to determine total blood
cells and differential cell count. In the second vial, blood
was allowed to clot and serum was collected through
centrifugation. Serum was stored at -80 ºC and was used
for estimation of IgE and cytokines levels.
2.7. Estimation of nitric oxide, nitrites, and cytokines in
serum and BAL fluid
The levels of various key inflammatory biomarkers like
IgE, IL-4, IL-5, IL-1β, LTD-4, and TNF-α in serum
and BAL fluid, were quantitatively assessed through
ELISA kits. The assays were performed according to the
instructions supplied with the commercial kits. Automatic
ELISA reader (Model no. ELX-80MS, Biotek, USA) was
used to analyze the samples. The UV kinetic method was
employed to quantify the concentration of nitrite and
nitric oxide in serum and BAL fluid.
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2.8. Statistical analysis
Pharmacological responses are represented as mean ±
SEM. To validate the results statistically with statistical
differences at 5% level of probability (p < 0.05), a oneway analysis of variance (ANOVA) followed by a post hoc
Tukey’s test was employed. All statistical calculations and
analyses were done using Graph Pad Prism software (San
Diego, CA, USA).
3. Results
3.1. Effect of MFE treatment on lung function parameters
Administration of methacholine caused a significant
increase in breathing rate (p < 0.001) in asthma control
animals (S) as compared to normal control animals
(N). Treating asthmatic animals with M. ferrea stamens
ethanolic extract (MFE), 3.75 mg/kg or 15 mg/kg, b.w.
reduced breathing rate by 26.72% (p < 0.05) and 32.75%
(p < 0.01) respectively, as compared to the asthma control
group (S). Remarkable (p < 0.001) decrease in lungs tidal
volume (VT) of the asthma control group (S) as compared
to normal control group (N) was also observed. Treating
asthmatic rats with MFE (3.75 mg/kg or 15 mg/kg, b.w.)
significantly improved VT by 12.5% (p < 0.05) or 26.78% (p
< 0.01), respectively (Figure 2). Oral treatment of asthmatic
animals with a reference standard, dexamethasone, also
improved lung functions, significantly (p < 0.001) in
comparison to the asthmatic control group (S).
3.2. Effect of MFE treatment on circulating cell count in
BAL fluid
Total leukocyte count (TLC) and differential cell
count (DLC), including lymphocytes, eosinophils, and
neutrophils in blood and BAL fluid samples of asthmatic
rats increased considerably (p < 0.001) in comparison to
normal control (N) group. However, in the study, a lesser
number of lymphocytes as compared to that of normal
group (N) were observed in the blood sample of OVAsensitized and challenged rats. Treating asthmatic rats
with MFE (15 mg/kg) or dexamethasone normalized the

circulatory cell count in blood as well as BAL fluid in
comparison to asthma control group (p < 0.05, p < 0.01
and p < 0.001) (Table 2). Reversal of OVA-induced altered
levels of circulatory cells after MFE treatment was found to
be comparable with that of dexamethasone in both body
fluids analysed.
3.3. Effect of MFE treatment on serum cytokines levels
Rats of the asthmatic control group (S) had shown a dramatic
increase in the concentration of various cytokines, IL-4,
LTD-4, IL-1β, IL-5, and TNF-α in serum after exposure
to ovalbumin in comparison to the nonasthmatic control
group (N) with statistical significance of (p < 0.001).
Treatment of asthmatic rats with MFE at a dose of 3.75
mg/kg and 15 mg/kg, b. w. significantly decreased elevated
serum levels of asthmatic biomarkers like IL-4, LTD-4, IL1β, IL-5, and TNF-α. MFE treatment at a lower dose of
3.75 mg/kg, b. w. (S + M1) declined elevated serum levels
of IL-4, IL-5, TNF-α, IL-1β, LTD-4, by 22.22%, 18.18%,
13.47%, 6.70%, and 13.13%, respectively, with confidence
interval of p < 0.05 in comparison to asthmatic control
group (S) (Figure 3).
At a dose of 15 mg/kg, b. w., MFE extract dampens
the elevated cytokines storm of IL-4, IL-5, TNF-α, IL-1β,
LTD-4, by 38.17% (p < 0.01), 29.32% (p < 0.01), 31.37%
(p < 0.01), 25.46% (p < 0.05), and 31.22% (p < 0.05),
respectively, in comparison to asthmatic control group (S)
(Figure 3). A similar comparison for S + D group showed
a significantly reduced concentration of all the cytokines
(p < 0.001) tested in our study. Comparing the efficacy of
MFE with standard reference dexamethasone, we found
that herbal drug was comparable in preventing OVAinduced changes in serum cytokines in rats, however, the
comparison was significant at both dose levels tested in
our study.
3.4. Effect of MFE treatment on cytokine levels in BAL
fluid
Level of all the inflammatory and proinflammatory
cytokines in the bronchial fluid of asthmatic animals (S)

Figure 2. Statistical analysis of effect of MFE treatment on lung functions, breathing rate (A) and tidal volume (B),
in different groups. Values are represented as mean ± S.E.M. *p < 0.05, **p < 0.01 and ***p < 0.001, compared to the
asthmatic control (S) group; ###p < 0.001 compared to normal control (N) group.
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Table 2. Estimation of total leucocyte count (TLC) and differential cell count in BAL fluid (×105 cells/mL).
Groups

N

S

S+D

S+M1

S+M2

Total cells

7.11 ± 0.46

13.37 ± 0.85###

8.06 ± 0.45***

9.43 ± 0.22*

7.68 ± 0.22**

Eosinophils

0.54 ± 0.49

11.42 ± 0.42###

3.48 ± 0.43***

7.83 ± 0.14ns

6.59 ± 0.41*

Lymphocytes

9.83 ± 0.42

20.33 ± 0.75###

10.37 ± 0.51***

14.09 ± 0.17*

13.12 ± 0.33*

Macrophages

5.29 ± 0.46

13.19 ± 0.76

6.72 ± 0.69

10.34 ± 1.66

8.44 ± 0.51*

Neutrophils

0.54 ± 0.08

5.69 ± 0.44###

1.99 ± 0.08***

3.38 ± 2.06*

2.79 ± 2.06***

###

***

ns

Values represent mean ± S.E.M (n = 6); *p < 0.05, **p < 0.01, ***p < 0.001 and ns (non-significant) compared to the asthmatic
control (S) group; ###p < 0.001 compared to normal control (N) group.

were found markedly high (p < 0.001) in comparison to
normal control group (N). Treatment with both doses
of MFE (3.75 mg/kg and 15 mg/kg) elicited substantial
reduction in cytokines level arises after ovalbumin
exposure in asthmatic rats. MFE treatment at lower dose
of 3.75 mg/Kg, b. w., (S + M1) declined elevated serum
levels of IL-4, IL-5, IL-1β, and TNF-α by 26.54%, 13.44%,
13.79%, and 11.27%, respectively, (p < 0.05) in comparison
to asthmatic control group (S) (Figure 3).
At a dose of 15 mg/kg, b. w., MFE extract inhibited
elevated cytokines storm of IL-4, IL-5, IL-1β, by 42.97%,
24.85%, and 27.25%, respectively, with a confidence interval
of p < 0.01 in comparison to the asthmatic control group
(S) (Figure 3). It was very interesting that MFE treatment
at 15 mg/kg, b. w. inhibits the TNF-α level in BAL fluid up
to 27.37% with p < 0.001 in comparison to the asthmatic
control group (S). MFE treatment (15 mg/kg) was able to
produce considerable reduction (37.95%) in concentration
of LTD-4 in BAL fluid after comparing with asthma control
group (S) animals (p < 0.05). In comparison to standard
reference dexamethasone, M. ferrea stamens extract was
found to be significantly comparable in reducing BAL fluid
levels of cytokines in OVA-sensitized animals.
3.5. Effect of MFE treatment on IgE levels of serum and
BAL fluid
IgE levels of both serum and BAL fluid samples of animals
increased significantly (p < 0.001) after OVA-sensitization
and challenge. A significant reduction of circulating IgE
levels in serum and BAL fluid by 13.96%, 29.67% was
observed after administration of MFE (3.75 mg/kg, b. w.)
in asthmatic challenged rats, respectively, in comparison
to untreated asthmatic rats (S). In a similar fashion,
29.67% and 28.05% decrease in circulating IgE levels in
serum and in BAL fluid was observed after administration
of 15 mg/kg, b. w. of MFE, respectively, in comparison
to untreated asthmatic rats (S). Treatment of asthmatic
animals with standard drug, dexamethasone also elicited
a significant (p < 0.001) reduction in IgE levels in both
the body fluids analysed (Figure 4). Further, the effect

of herbal drug treatment in attenuating serum and BAL
fluid levels of allergen-induced IgE levels were found to be
statistically significant when compared with the reference,
dexamethasone.
3.6. Effect of MFE treatment on total nitric oxide and
nitrite concentration
In asthmatic rats (S), total NO and nitrite concentrations
in body fluids were increased significantly (p < 0.001)
in comparison to normal group (N). Animals receiving
MFE at a dose level, 15 mg/kg b. w., exhibited a reduction
in nitric oxide in serum and BAL fluid by 28.77% and
31.15%, respectively, in comparison with the asthmatic
control group (S). Animals receiving MFE, 15 mg/kg b.
w., also exhibited a reduction in nitrite content in serum
and BAL fluid by 39.49% and 58.75% in serum as well as
BAL fluid (p < 0.05), respectively (Figure 5) in comparison
with the asthmatic control group (S). Reference drug,
dexamethasone, and higher dose of the extract also
showed a significant reduction in elevated levels of both
the analytes (p < 0.001). Reduction in serum and BAL
fluid levels of total NO and nitrite after MFE treatment was
comparable to standard drug treatment.
4. Discussion
The recent resurge in the interest of researchers to
utilise plants as a source of novel therapeutically active
interventions can be advocated for the presence of multidimensional chemical structures with varied biological
functions. Due to the complex nature of chronic diseases
e.g., asthma, the treatment strategy has shifted to a multitarget approach with combination agents. It is known
that spasmogenic and contractile responses of airway
smooth muscles are tightly regulated by neurotransmitters
and other biological chemicals including acetylcholine,
histamine, bradykinin, etc. (Canning, 2006). In sensitized
individuals, allergen exposure activates naive T cells
(TH0) that lead to excessive production of TH2 cells in
comparison to TH1. Activated TH2 cells by producing
cytokines and other biologically active molecules are
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Figure 3. Statistical analysis of effect of MFE treatment on various estimations in different groups; serum cytokines levels (A-E)
and BAL fluid cytokines levels (F-J) of different treatment groups. Data represent mean ± S.E.M. *p < 0.05, *p < 0.01 and ***p <
0.001, compared to the asthmatic control (S) group; ###p < 0.001 compared to normal control (N) group.

key components in the pathogenesis of asthma. Among
these cytokines, IL-4 and IL-5 are mainly implicated in
cardinal features of asthma, maturation of eosinophils and
goblet cell, IgE mediated hypersensitive response, mucus
secretion, bronchial constriction, and tissue remodelling
(Lambrecht et al., 2019).
Upon allergen recognition, and cross-linking of IgE
with high affinity receptors, FcεRI (Fc epsilon RI) present
on mast cells and the low affinity receptors FcεRII or CD23
cells present on antigen presenting cells activate mast cell
(Bax et al., 2012; Samitas et al., 2015). Activation results in
the release of primary and secondary chemical substances
(e.g., histamine, heparin, and proteases) and inflammatory
mediators, such as cytokines and arachidonic acid

826

metabolites (Heather et al., 2012). Lately, it has been
found that the newly formed Ag-FcεRI-IgE (allergenFcεRI-IgE) complex also accelerates the production of
chemokine ligand 28 (CCL28), that selectively attracts TH2
lymphocytes production (Matucci et al., 2018).
IL-4 is a key player in establishing the basis for IgEmediated hypersensitivity reactions. IL-4 upregulates the
transcription factor, GATA-3 in naive-T cells, thereby,
regulating differentiation of allergen-specific T helper cells
(Zhu et al., 2010). Excessive production of IL-5 in airways
favours growth, survival, accumulation, and activation of
eosinophils in the lungs (Roufosse, 2018).
In the present study, allergen sensitization elicited
marked alteration in breathing rate and lung tidal volume.
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Figure 4. Statistical analysis of effect of MFE treatment on various estimations in different groups (i) serum IgE
levels (A); (ii) BAL fluid IgE levels (B). Values are represented as mean ± S.E.M. (n = 6); ###represents p < 0.001
compared to normal control (N); *represents p < 0.05, ** represents p < 0.01 and ***represents p < 0.001, compared
to the asthmatic animals (S).

Figure 5. Statistical analysis of effect of MFE treatment on various estimations in different groups nitric oxide
(NO) and nitrites serum (A and B) and BAL fluid levels (C and D). Values are represented as mean ± S.E.M. (n
= 6); ###represents p < 0.001 compared to normal control (N); *represents p < 0.05, ** represents p < 0.01 and
***represents p < 0.001, compared to the asthmatic animals (S).

Further, all the asthmatic control group animals (S) have
shown all the symptoms and manifestations of asthma
that include coughing, irritability, and breathing difficulty.
Persistent inflammation of airways in asthma obstructs
air flow resulting in bronchoconstriction and dyspnoea.
However, treatment of OVA-sensitized animals with MFE
and dexamethasone prevented methacholine-induced
bronchoconstriction. Broncho-relaxant effects of the drugs
in the current study can be advocated antiinflammatory
effects of MFE on airways.

In the study, allergen provocation of sensitized rats
altered the normal count of inflammatory cells, including
eosinophils, lymphocytes, and neutrophils in blood as well
as BAL fluid of experimental animals when compared with
normal control group. Eosinophils are directly associated
with TH2 immune response in asthma and have pleiotropic
effects on various inflammatory cells (Petsky et al., 2012).
Several pieces of studies demonstrate that controlling
eosinophil count leads to decreased asthma exacerbations
in allergic patients. Oral administration of MFE (3.75 and
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Figure 6. Proposed mode of action of Mesua ferrea stamen extract. IL, Interleukin; TNF-α, tumor necrosis factor; LT-D-4,
leukotriene D, IgE, Immunoglobulin E; B cells, B lymphocytes (cells), TH0, Naive T helper cells; TH2, T helper type 2 cells.

15 mg/kg, b.w.) for 28 days in asthmatic rats efficiently
suppressed allergen-induced inflammation cascade
and inhibited migration of immune cells particularly of
eosinophils in rat’s lung, demonstrating the prospective
role of the herbal extract in bronchial asthma.
Neutrophils are the first inflammatory respondent
that directly or indirectly activates other inflammatory
mediators to release a storm of cytokines, myeloperoxidase,
COX-2, and LOX-5 enzymes and accelerate and augment
the inflammatory response (Tanaka et al., 2006, Dileepan
et al., 2019). Neutrophils secrete an enzyme known as
elastase that acts as a potent secretagogue in airways and
cause goblet cell hypersecretion (Nadel et al., 1999). In
our studies, treating asthmatic animals with MFE at both
doses (3.75 and 15 mg/kg), resulted in reduced neutrophil
count in both blood as well as BAL fluid of treated animals.
Significant reduction in neutrophils can be owed to the
presence of bioflavonoids, rhusflavanone or mesuaferrone
B, and pentacyclic triterpenoids, such as α-amyrin or
β-amyrin, present mainly in stamens of M. ferrea. These
triterpenoids are reported to have multiple biological
functions, including modulation of leucocyte migration
and neutrophil infiltration in the asthmatic lungs,
antihistaminic activity, antiallergic activity, mast cells
stabilisation, myeloperoxidase (MPO) inhibitory activity
(Oliveira et al. 2004, Okoye et al., 2014). Rhusflavanone
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and mesuaferrone B exhibit potent human leukocyte
elastase inhibitory activity in in vitro studies (Zar Wynn
Myint et al., 2021).
Another two sesquiterpenes, largely present in
M. ferrea flowers are germacrene D and α-copaene.
Germacrene D impedes production of reactive oxygen
species in neutrophils and sojourn N-formylmethionylleucyl-phenylalanine (fMLF)-induced neutrophil Ca2+
mobilization. Thus, MFE has the ability to modulate
fMLF-induced neutrophil migration and chemotaxis
in dose dependent manner (Schepetkin et al., 2020).
α-Copaene is reported as potential phosphatidyl-inositol
3-kinases (PI3Ks) inhibitor. In asthma pathology, PI3Ks
play a vital central signallingrole. PI3Ks inhibition drops
the mucus production, averts degradation of mast cells,
assists bronchodilation and discourages immune cell
conscription thus helps in the management of allergic
asthma (Queiroz et al., 2014; Yoo et al., 2017).
TH2 mediators, TNF-α, IL-5, IL-4, IL-1ß play a primary
role in coordinating various inflammatory mechanisms in
asthma. Therapeutic approaches targeting IL-4, IL-5, and
TNF-α through their selective inhibitors are under clinical
trials in management of asthma. In our study, presence of
TH2 cytokines in asthmatic animals indicates perpetuating
airway inflammation in sensitized lungs. Oral treatment
of asthmatic rats with MFE (3.75 or 15 mg/kg) reversed
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(IL)-4, -5, and TNF-α levels in both body fluids (serum
and BAL) of animals in comparison to the asthma group.
Effects produced by MFE at higher doses were significant
and comparable to that of corticosteroid, used as a standard
drug in the study (2.5 mg/kg). Cysteinyl leukotrienes
(cys LTs) represent biologically active arachidonic acid
metabolites and account for clinical features of asthma
(Laidlaw and Boyce, 2012). Cysteinyl leukotrienes mediate
biological effects through G-protein receptors CysLTR (13). CysLT1R is mainly present in bronchial muscles and has
a higher affinity to LTD4. Market available montelukast,
zafirlukast specifically antagonise CysLT1R (Al-Azzam
and Elsalem, 2020). In our study, standardized MFE extract
treatment also significantly ameliorated OVA-induced
increased levels of IL-1β and cysteinyl leukotrienes
(LTD4) in serum and BAL fluid of asthmatic animals as
compared to OVA-control group. Marked reversal of LTD4 levels after treatment of asthmatic animals with MFE
demonstrate possible antagonistic effects of herbal extract
at CysLT1R as similar to market drugs.
Serum Immunoglobulin E (sIgE) levels are high in
asthmatic individuals as compared to normal subjects and
these levels increase with the severity of asthma making
it a strong clinically predisposing factor in the bronchial
asthma. Oral administration of MFE at both doses (3.75
and 15 mg/kg) was found to be effective in reducing
IgE titer in both blood/serum and BAL fluid of treated
animals. Decreased concentration of IgE can be related
to suppression of histamine release from mast cells and
demonstrates antiallergic role of the plant.
Inflammatory cells in asthmatic individuals are capable
of producing several fold more free oxygen radicals and
nitrites by autooxidation of nitric oxide molecule (NO)
(Bhujbal et al., 2010). An increase in generation of NO,
called ‘nitrosative stress’, contributes to ongoing process
of inflammatory process in airways. The nitric oxide is
produced during the production of the L-citrulline from
L-arginine by iNOS (inducible nitric oxide synthase),
which, in turn, inhibits the arginase activity. iNOS is
also induced by biochemicals, such as TNF-α, IL-1ß and
stimulates the formation of nitric oxide. Nitrate (NO3-)
and nitrite (NO2-) radicals are metabolite products of NO
oxidation (Zuo et al., 2014). Studies report that acidic pH
in asthmatic airways may facilitate conversion of nitrite
to NO. NO2−/NO3− and FENO (fractional exhaled nitric
oxide) levels may be considered as biological markers to
relate it with intensity of allergic sensitisation (Fernando
et al., 2020). In the current study, investigating the role of
MFE on NO and nitrites in blood and BAL fluid of allergen
sensitized rats, the crude drug extract was found to reduce
levels of both gaseous radicals in a significant manner.
These results may be correlated due to the presence of
antioxidant phytoconstituents, xanthones, flavonoids,

α-amyrin, β-amyrin, germacrene D, and α-Copaene in the
plant part.
Potential role of M. ferrea ethanolic (70%) extract
observed in our study is assumed to be related to the
presence of sesquiterpenes, phenolics, and steroidal
compounds present in the plant as mentioned elsewhere.
We had chosen 70% ethanol for extraction and
pharmacological in our previous preliminary experiments,
maximum %extractive yield of M. ferrea was obtained
hot extraction using a solvent mixture of ethanol : water
(7 : 3). In addition, maximum flavonoid and phenolic
content (w/w) was also analysed in MFE. Though due to
lack of analytic facilities in our lab, it was not possible to
quantitatively standardize the crude herbal extract for
specific biomarkers. However, collective piece of evidence
shows that pentacyclic tripterpenoids, bioflavanoids
(Rhusflavanone and mesuaferrone B), and phenolic
compounds exhibit large physiological antiasthmatic and
antiinflammatory activities in laboratory animals.
The phenolic compounds intervene in cell
transduction pathways mediated via GATA-3 and RORγt
(transcription factors of the RAR-related orphan nuclear
receptor (ROR) family) mechanism, major pathways in
maintaining balance of TH1/TH2 in allergic conditions
(Nadif et al., 2014). In preclinical studies, gallic acid a
phenolic compound present widely in plants, reduces
airway resistance, eosinophil infiltration, interleukin -5,
-13 levels in BAL fluid and IL-33 expression in lungs by
inhibiting MyD88 expression and downregulating nuclear
factor (NF)-κB signaling (Arora et al., 2011; Wang et al.,
2018). IL-33 inhibition by gallic acid results in inactivation
of type 2 innate lymphoid cells (ILC2) and Th2 mediated
cytokine release. Quercetin ameliorates the stability of
Th1/Th2 phenotype, histamine production, release of
proinflammatory mediators and antigen-specific IgE
antibody by B cells (Jafarinia et al., 2020). Kaempferol curbs
the Tyk-STAT signalling mediated through eotaxin-1 and
eotaxin receptor CCR3. It also inhibits TLR-4 activation
and decreases the production of IL-8, IL-4, IL-5, IL-13,
and TNF-α by inhibiting Akt phosphorylation (Gong et
al., 2013; Chung et al., 2015). Similarly, alleviations in
levels of different cytokines by luteolin treatment in animal
as well as in human subjects are also documented (Das
and Ghosh, 2003; Liang et al., 2020). Triterpenoid lupeol
significantly modulates the level of type II cytokines (IL-4,
IL-5 and IL-13) during in vivo experiments (Vasconcelos
et al., 2008). Similarly, apigenin has ability to modulate
levels of proinflammatory mediators IL-1β, TNF-α, NO,
lymphocytes and neutrophils levels in vitro studies (Lago
et al., 2014). Similar pharmacological effects in animal
models of asthma have been observed with phytosterol
β-sitosterol (Mahajan and Mehta, 2011). Accumulating
all evidence, we can presume that presence of phenolic
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and triterpenoids bioactives in M. ferrea stamens could be
collectively responsible for therapeutic role of herbal drug
in bronchial asthma.
Our findings suggest that MFE could exert
antiasthmatic effects in experimental rats by regulating
TH2 related cytokines production in lungs, mainly IL4,
IL5, and others. The suggested mode of action of Mesua
ferrea stamens is depicted in Figure 6. Reduced levels of
TH2 derived cytokines could inhibit secretion of IgE and
thereby, suppress degranulation of mast cells and release
of several cytokines, chemokines that might ameliorate
airway inflammation cascade and ROS generation in lungs
(Mahajan and Mehta, 2011). These studies demonstrate
multiple targets underlying preventive effect of our herbal
drug in bronchial asthma. Despite promising results, the

clinical approach towards use of Mesua ferrea stamens in
asthma therapy needs detailed pharmacological studies at
cellular and molecular levels.
5. Conclusion
The results of our study statistically proved and suggest
the potential role of Mesua ferrea stamens extract in
the treatment and management of allergic asthma by
attenuating ongoing inflammatory processes, mediated
via inhibiting subsequent infiltration of eosinophils,
lymphocytes, neutrophils into lungs airways, and release
of inflammatory and proinflammatory mediators. Further,
studies on bioactives present in M. ferrea may be advised
to investigate its mechanism of action at molecular and
cellular levels.
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